2023 J.C. Kennedy Foundation, GTSN-PCF
Challenge Award
Targeting Neuroendocrine Cells in Prostate Cancer with Small Molecule and Targeted Radionuclide Therapies
Principal Investigators: Andrew Armstrong, MD (Duke University), Jiaoti Huang, MD (Duke University)
Co-Investigators: Michael Zalutsky, PhD (Duke University), Susan Halabi, PhD (Duke University), Kent Weinhold, PhD (Duke University)
Young Investigator: Fan Zhang, PhD (Duke University), Yutian Feng, PhD (Duke University)
2023 Republic National Distributing Company
(RNDC)-PCF Challenge Award
Development of a CBP/p300 Degrader for the Treatment of Castration-Resistant Prostate Cancer
Principal Investigators: Arul Chinnaiyan, MD, PhD (University of Michigan), Shaomeng Wang, PhD (University of Michigan), Ulka Vaishampayan, MBBS (University of Michigan), Abhijit Parolia, PhD (University of Michigan)
Young Investigator: Jie Luo, PhD (University of Michigan)
Co-Investigators: Jeremy Taylor, PhD (University of Michigan), Yuanyuan Qiao, PhD (University of Michigan
2023 Bayer-PCF Health Equity Research Award
Incorporating Patient Education into Germline Genetic Testing in Black Patients with Prostate Cancer
Principal Investigator: Burcu Darst, PhD (Fred Hutchinson Cancer Center)
Young Investigator: Hiba Khan, MD, MPH (University of Washington)
Co-Investigators: Heather Cheng, MD, PhD (University of Washington), Manoj Menon, MD, MPH (Fred Hutchinson Cancer Center), Yaw Nyame, MD, MS (University of Washington)
Collaborator: Veda Giri, MD (Yale University)
2023 PCF Challenge Award
Personalizing Treatment Decisions Through Composite Next Generation Imaging and Liquid Biomarker Development Within a Phase II Randomised Trial of Enzalutamide (+/-177Lu-PSMA-617) (ENZAp)
Principal Investigator: Louise Emmett, MD, MBBS (St Vincent’s Hospital Sydney, Australia)
Young Investigators: Edmond Kwan, MBBS, PhD (University of British Columbia), Megan Crumbaker, MD, PhD (St Vincent’s Hospital Sydney), Andrei Gafita, MD (Johns Hopkins University), Narjess Ayati, MD (St Vincent’s Hospital Sydney)
Co-Investigators: Michael Hofman, MBBS (Peter MacCallum Cancer Centre), Ian Davis, MBBS, PhD (Monash University), Alexander Wyatt, PhD (University of British Columbia), Andrew Martin, PhD (University of Sydney), Shahneen Sandhu, MD, PhD (Peter MacCallum Cancer Centre), Martin Stockler, MBBS, PhD (University of Sydney), Felix Feng, MD (University of California, San Francisco), Martin Sjostrom, MD, PhD (University of California, San Francisco), Nathan Papa, MBBS, PhD (Garvan Institute of Medical Research)
2023 Sun Pharma-PCF VAlor Special Challenge Award
A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans with Castrate-Sensitive Prostate Cancer
Principal Investigators: Antonio Tito Fojo, MD (James J. Peters Veterans Affairs Medical Center), Susan Bates, MD (James J. Peters Veterans Affairs Medical Center)